
Effect of Trilaciclib on Myelosuppression in Previously Treated Extensive-Stage Small-Cell Lung Cancer Cancer Network
Researchers evaluated the effect of trilaciclib to a topotecan regimen in reducing chemotherapy-induced myelosuppression in newly diagnosed extensive-stage …
